<DOC>
	<DOCNO>NCT00615615</DOCNO>
	<brief_summary>Double-blind , randomize , placebo-controlled , multi-center clinical trial conduct evaluate levetiracetam adjunctive therapy child ( 4-16 year ) refractory partial onset seizure .</brief_summary>
	<brief_title>Efficacy Tolerability Levetiracetam Add-On Treatment Refractory Pediatric Patients With Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>diagnosis epilepsy uncontrolled partial onset seizure , whether secondarily generalize , diagnosis &gt; = 6 month Selection Visit ; epilepsy classifiable accord ILAE Classification ; &gt; = 4 partial onset seizures 4 week precede Selection Visit require &gt; = 4 partial onset seizures 4week interval Baseline Period qualify randomization ; unsatisfactory current AED treatment term efficacy and/or safety ; stable AED treatment consist two AEDs . treatable seizure etiology ; epilepsy secondary progressive cerebral disease progressively neurodegenerative disease , include Rasmussen LandauKleffner diseases ; history status epilepticus require hospitalization 3 month prior Selection Visit ; history presence pseudo seizure ; current diagnosis LennoxGastaut syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra</keyword>
</DOC>